The latest happenings of the past month, all in one place.
MMS announced the growth of its leadership team with the appointment of Kelly J. Hill to Executive Vice President of Global Business Operations and Strategy, and Michelle Gayari to Executive Vice President of Global Operational Excellence and Innovation. The company also announced that Arunima Sen, MD, Director of Pharmacovigilance and Medical Writing (India), has been appointed to the Indian Society of Clinical Research’s Pharmacovigilance Council.
CTMA has appointed Arnaud Marcel as the new Chief Technology Officer.
Calyx announced that Craig M. Mooney joined the company as Vice President of Science and e-Tech Enabled Services.
PHASTAR announced the appointment of Chuck Gelb as Chief Commercial Officer.
Steve Rosenberg has joined uMotif's Board of Directors.
Imaging Endpoints announced that it has established a new office located in the Vorstaedte District of Basel, Switzerland.
THREAD has been awarded Frost & Sullivan’s 2021 Customer Value Leadership Award. Additionally the company has announced that worldwide analyst Everest Group has deemed them a Leader in the DCT sector.
Sensyne Health plc has reached a milestone of access to a combined clinical research, clinical trial, and real world de-identified and anonymized dataset of over 60 million patients.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.